A federal magistrate judge recommended certifying a nationwide class action in a federal court in Miami, which is scheduled for trial Oct. 26 and alleges a pharmaceutical company sold a “worthless” product that was designed to help with memory loss.

On Thursday, U.S. Magistrate Judge Jonathan Goodman of the the Southern District of Florida recommended certifying a class of consumers who purchased Prevagen over the last four years. The Moskowitz Law Firm and Searcy Denney will represent the plaintiffs at trial.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]